Pharma
Samsung, Massachusetts General Hospital team up to study GLP-1 muscle loss
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
GLP-1s
How GLP-1s is shaping the future of healthcare, featuring expert insights, data-driven stories, and the latest industry developments.
Pharma
How Eli Lilly’s oral GLP-1 could change the obesity drug market
A hot new GLP-1 bombshell has entered the villa.
Pharma
Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race
The G in GLP-1 might as well stand for gold.
Pharma
Serena Williams as Ro’s celeb ambassador could mark ‘a big shift’ in pharma advertising
Pharma isn’t known for big-name celebrity appearances, but Ro’s approach could change the landscape.
Pharma
What’s the difference between the GLP-1s on the market?
From semaglutide vs. tirzepatide to Ozempic vs. Wegovy.
Pharma
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
Pharma
What’s next for GLP-1s?
Because who doesn’t prefer swallowing a pill over getting a shot?
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
